Dogs’
immune systems are often put at risks when they begin chemotherapy for canine
lymphoma cancer. Recent studies at Texas A&M University and University ofTexas MD Anderson Cancer Center have since found that the t- cells taken from a
dog before chemotherapy is begun can be cultured to produce more of the
important t-cells and be implanted back into the blood stream once the
chemotherapy is completed, which can help fight the B-cell lymphoma.
immune systems are often put at risks when they begin chemotherapy for canine
lymphoma cancer. Recent studies at Texas A&M University and University ofTexas MD Anderson Cancer Center have since found that the t- cells taken from a
dog before chemotherapy is begun can be cultured to produce more of the
important t-cells and be implanted back into the blood stream once the
chemotherapy is completed, which can help fight the B-cell lymphoma.
One
of the Veterinary Oncologists at Texas A&M, Dr. Heather Wilson, explains
how her results were better than expected and looking forward to moving along
with the study. The next phase would include, genetically altering the t-cells
to make them more specific, allowing for long term remission. It is thought
that it has very minimal side-affects and seems to be a perfect option for
humans who can’t tolerate chemotherapy’s harsh side effects, especially for
young children.
One
of the main problems with canine lymphoma cancer is that dogs given standard chemotherapy
often only experience one year of durable remission, along with the
side-affects.
of the main problems with canine lymphoma cancer is that dogs given standard chemotherapy
often only experience one year of durable remission, along with the
side-affects.
Did
you find this information helpful? Check out more helpful ways to protect and
care for you furry friends on our Facebook page!
you find this information helpful? Check out more helpful ways to protect and
care for you furry friends on our Facebook page!
